Treating/preventing heart failure via inhibition of mast cell de

Details Treating/preventing heart failure via inhibition of mast cell de Treating/preventing heart failure via inhibition of mast cell de

1998-09-18

1999-09-14

Henley, III, Raymond

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514456, A61K 31445, A61K 3135

Patent

active

059523530

ABSTRACT:
Heart failure is treated/prevented by administering to candidate subjects inhibitors of mast cell degranulation, for example nedocromil sodium or cromolyn sodium, to prevent adverse myocardial remodeling secondary to a sustained blood volume overload.

REFERENCES:
patent: 4474787 (1984-10-01), Cairns et al.
patent: 4918078 (1990-04-01), Brown et al.
patent: 4935244 (1990-06-01), Clark
patent: 5049389 (1991-09-01), Radhakrishnan
patent: 5474983 (1995-12-01), Kuna et al.
patent: 5629322 (1997-05-01), Guthikonda et al.

Affiliated with

Also associated with

Rating

Treating/preventing heart failure via inhibition of mast cell de does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treating/preventing heart failure via inhibition of mast cell de, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating/preventing heart failure via inhibition of mast cell de will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1510108